Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer

  Free Subscription


06.11.2017

1 Acta Biomed
1 Acta Cytol
1 Acta Radiol Open
1 Arch Gynecol Obstet
1 Asian Pac J Cancer Prev
1 Biochim Biophys Acta
1 Biomed Pharmacother
1 BMC Res Notes
2 Br J Radiol
2 Brachytherapy
1 Breast Cancer
1 Can J Ophthalmol
1 Cancer Cell Int
1 Cancer Res
1 Cancer Res Treat
1 Cell Cycle
2 Chaos
1 Chem Biol Drug Des
1 Clin Transl Oncol
2 Gynecol Oncol
1 Gynecol Oncol Res Pract
1 In Vitro Cell Dev Biol Anim
1 Infect Dis Obstet Gynecol
1 Int J Clin Pharmacol Ther
1 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
1 J Exp Clin Cancer Res
7 J Glob Oncol
1 J Womens Health (Larchmt)
1 JAMA Oncol
1 Mol Carcinog
4 Oncol Lett
3 Oncotarget
1 Pak J Pharm Sci
1 Pathol Oncol Res
1 PeerJ
1 Pharmacoeconomics
1 PLoS Med
1 PLoS One
2 PLoS Pathog
3 Prev Med
1 Probiotics Antimicrob Proteins
1 Proc Natl Acad Sci U S A
1 Strahlenther Onkol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Biomed

  1. PELLEGRINO A, Damiani GR, Loverro M, Pirovano C, et al
    Comparison of Robotic and laparoscopic Radical type-B and C hysterectomy for cervical cancer: Long term-outcomes.
    Acta Biomed. 2017;88:289-296.
    PubMed     Text format     Abstract available


    Acta Cytol

  2. POSSATI-RESENDE JC, Vazquez FL, Biot ST, Mauad EC, et al
    Organized Cervical Cancer Screening Program in Barretos, Brazil: Experience in 18 Municipalities of Sao Paulo State.
    Acta Cytol. 2017 Oct 26. doi: 10.1159/000480446.
    PubMed     Text format     Abstract available


    Acta Radiol Open

  3. BECKER AS, Ghafoor S, Marcon M, Perucho JA, et al
    MRI texture features may predict differentiation and nodal stage of cervical cancer: a pilot study.
    Acta Radiol Open. 2017;6:2058460117729574.
    PubMed     Text format     Abstract available


    Arch Gynecol Obstet

  4. KOLBEN TM, Bergauer F, Moeckel J, Boettcher B, et al
    Short interval between two Pap smears: effect on the result of the second smear? A prospective randomized trial.
    Arch Gynecol Obstet. 2017;295:1427-1433.
    PubMed     Text format     Abstract available


    Asian Pac J Cancer Prev

  5. AL-RIFAI RH, Loney T
    Factors Associated with a Lack of Knowledge of Performing Breast Self-Examination and Unawareness of Cervical Cancer Screening Services: Evidence from the 2015 Egypt Health Issues Survey
    Asian Pac J Cancer Prev. 2017;18:2763-2769.
    PubMed     Text format     Abstract available


    Biochim Biophys Acta

  6. ROYCHOWDHURY A, Samadder S, Das P, Mandloi S, et al
    Integrative genomic and network analysis identified novel genes associated with the development of advanced cervical squamous cell carcinoma.
    Biochim Biophys Acta. 2017;1861.
    PubMed     Text format     Abstract available


    Biomed Pharmacother

  7. ZHANG Z, Wang J, Li J, Wang X, et al
    MicroRNA-150 promotes cell proliferation, migration, and invasion of cervical cancer through targeting PDCD4.
    Biomed Pharmacother. 2017;97:511-517.
    PubMed     Text format     Abstract available


    BMC Res Notes

  8. CAROW K, Read C, Hafner N, Runnebaum IB, et al
    A comparative study of digital PCR and real-time qPCR for the detection and quantification of HPV mRNA in sentinel lymph nodes of cervical cancer patients.
    BMC Res Notes. 2017;10:532.
    PubMed     Text format     Abstract available


    Br J Radiol

  9. YOSHIHIRO U, Shingo O, Masaru I, Masayoshi M, et al
    Strategies for reducing ovarian dose in volumetric modulated arc therapy (VMAT) for postoperative uterine cervical cancer.
    Br J Radiol. 2017 Nov 3:20160777. doi: 10.1259/bjr.20160777.
    PubMed     Text format     Abstract available

  10. LUO HC, Lin GS, Liao SG, Wang FM, et al
    Cervical cancer treated with reduced-volume intensity-modulated radiation therapy base on Sedlis criteria (NCCN VS. RTOG).
    Br J Radiol. 2017 Oct 26:20170398. doi: 10.1259/bjr.20170398.
    PubMed     Text format     Abstract available


    Brachytherapy

  11. WEAVER J, Harmon G, Harkenrider MM, Surucu M, et al
    Delineating the relationship between Point A prescription dose and pelvic lymph node doses in intracavitary high-dose-rate brachytherapy treatment of cervical cancer for use in low- and middle-income countries.
    Brachytherapy. 2017 Oct 21. pii: S1538-4721(17)30457.
    PubMed     Text format     Abstract available

  12. FREDMAN E, Traughber B, Podder T, Colussi V, et al
    3T multiparametric MRI-guided high-dose-rate combined intracavitary and interstitial adaptive brachytherapy for the treatment of cervical cancer with a novel split-ring applicator.
    Brachytherapy. 2017 Oct 30. pii: S1538-4721(17)30465.
    PubMed     Text format     Abstract available


    Breast Cancer

  13. HARAO M, Ando J, Kamata H, Hoshi N, et al
    Peritoneal cancer arising after total abdominal hysterectomy and bilateral salpingo-oophorectomy for cervical cancer in a patient with right breast cancer and germline mutation of BRCA1 gene: a case report and literature review.
    Breast Cancer. 2017 Nov 1. doi: 10.1007/s12282-017-0813.
    PubMed     Text format     Abstract available


    Can J Ophthalmol

  14. NASH S, Bartels H, Pemberton J
    Metastatic cervical adenocarcinoma to the orbital subperiosteal space.
    Can J Ophthalmol. 2017;52:e60-e62.
    PubMed     Text format    


    Cancer Cell Int

  15. TANG H, Wang Y, Zhang B, Xiong S, et al
    High brain acid soluble protein 1(BASP1) is a poor prognostic factor for cervical cancer and promotes tumor growth.
    Cancer Cell Int. 2017;17:97.
    PubMed     Text format     Abstract available


    Cancer Res

  16. SONG KH, Choi CH, Lee HJ, Oh SJ, et al
    HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells.
    Cancer Res. 2017;77:5039-5053.
    PubMed     Text format     Abstract available


    Cancer Res Treat

  17. KWON J, Eom KY, Kim YS, Park W, et al
    The Prognostic Impact of the Number of Metastatic Lymph Nodes and a New Prognostic Scoring System for Recurrence in Early-Stage Cervical Cancer with High Risk Factors: A Multicenter Cohort Study (KROG 15-04).
    Cancer Res Treat. 2017 Oct 24. doi: 10.4143/crt.2017.
    PubMed     Text format     Abstract available


    Cell Cycle

  18. FENG C, Ma F, Hu C, Ma JA, et al
    SOX9/miR-130a/CTR1 axis modulates DDP-resistance of cervical cancer cell.
    Cell Cycle. 2017 Nov 3:1-34. doi: 10.1080/15384101.2017.1395533.
    PubMed     Text format     Abstract available


    Chaos

  19. AMEMIYA T, Shibata K, Itoh Y, Itoh K, et al
    Publisher's Note: "Primordial oscillations in life: Direct observation of glycolytic oscillations in individual HeLa cervical cancer cells" [Choas 27, 104602 (2017)].
    Chaos. 2017;27:109901.
    PubMed     Text format    

  20. AMEMIYA T, Shibata K, Itoh Y, Itoh K, et al
    Primordial oscillations in life: Direct observation of glycolytic oscillations in individual HeLa cervical cancer cells.
    Chaos. 2017;27:104602.
    PubMed     Text format     Abstract available


    Chem Biol Drug Des

  21. WANG X, Yi Y, Lv Q, Zhang J, et al
    Novel 1,3,5-Triazine Derivatives Exert Potent Anti-cervical Cancer Effects by Modulating Bax, Bcl2, and Caspases Expression.
    Chem Biol Drug Des. 2017 Oct 25. doi: 10.1111/cbdd.13133.
    PubMed     Text format     Abstract available


    Clin Transl Oncol

  22. ZHOU YM, Freese C, Meier T, Go D, et al
    The absolute volume of PET-defined, active bone marrow spared predicts for high grade hematologic toxicity in cervical cancer patients undergoing chemoradiation.
    Clin Transl Oncol. 2017 Oct 26. doi: 10.1007/s12094-017-1771.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  23. NING MS, Ahobila V, Jhingran A, Stecklein SR, et al
    Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer.
    Gynecol Oncol. 2017 Oct 28. pii: S0090-8258(17)31420.
    PubMed     Text format     Abstract available

  24. LAAN JJ, van Lonkhuijzen LRCW, van Os RM, Tytgat KM, et al
    Socioeconomic status as an independent risk factor for severe late bowel toxicity after primary radiotherapy for cervical cancer.
    Gynecol Oncol. 2017 Oct 23. pii: S0090-8258(17)31416.
    PubMed     Text format     Abstract available


    Gynecol Oncol Res Pract

  25. DEGU A, Njogu P, Weru I, Karimi P, et al
    Assessment of drug therapy problems among patients with cervical cancer at Kenyatta National Hospital, Kenya.
    Gynecol Oncol Res Pract. 2017;4:15.
    PubMed     Text format     Abstract available


    In Vitro Cell Dev Biol Anim

  26. CHEN L, Liu L, Li Y, Gao J, et al
    Melatonin increases human cervical cancer HeLa cells apoptosis induced by cisplatin via inhibition of JNK/Parkin/mitophagy axis.
    In Vitro Cell Dev Biol Anim. 2017 Oct 25. doi: 10.1007/s11626-017-0200.
    PubMed     Text format     Abstract available


    Infect Dis Obstet Gynecol

  27. ASERLIND A, Maguire K, Duthely L, Wennin S, et al
    Women Living with HIV over Age of 65: Cervical Cancer Screening in a Unique and Growing Population.
    Infect Dis Obstet Gynecol. 2017;2017:2105061.
    PubMed     Text format     Abstract available


    Int J Clin Pharmacol Ther

  28. LIU J, Fan H, Qiu GP
    Vascular permeability determined using multi-slice spiral CT perfusion can predict response to chemoradiotherapy in patients with advanced cervical squamous cell carcinoma.
    Int J Clin Pharmacol Ther. 2017;55:619-626.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  29. BAUER-NILSEN K, Hill C, Trifiletti DM, Libby B, et al
    Evaluation of Delivery Costs for External Beam Radiation Therapy and Brachytherapy for Locally Advanced Cervical Cancer Using Time-Driven Activity-Based Costing.
    Int J Radiat Oncol Biol Phys. 2017 Sep 14. pii: S0360-3016(17)33855.
    PubMed     Text format     Abstract available


    J Clin Oncol

  30. FRENEL JS, Le Tourneau C, O'Neil B, Ott PA, et al
    Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1-Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial.
    J Clin Oncol. 2017 Nov 2:JCO2017745471. doi: 10.1200/JCO.2017.74.5471.
    PubMed     Text format     Abstract available


    J Exp Clin Cancer Res

  31. DONG P, Xiong Y, Hanley SJB, Yue J, et al
    Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation.
    J Exp Clin Cancer Res. 2017;36:150.
    PubMed     Text format     Abstract available


    J Glob Oncol

  32. GOTTSCHLICH A, Rivera-Andrade A, Grajeda E, Alvarez C, et al
    Acceptability of Human Papillomavirus Self-Sampling for Cervical Cancer Screening in an Indigenous Community in Guatemala.
    J Glob Oncol. 2017;3:444-454.
    PubMed     Text format     Abstract available

  33. ARROSSI S, Temin S, Garland S, Eckert LO, et al
    Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline.
    J Glob Oncol. 2017;3:611-634.
    PubMed     Text format     Abstract available

  34. LOPEZ MS, Baker ES, Milbourne AM, Gowen RM, et al
    Project ECHO: A Telementoring Program for Cervical Cancer Prevention and Treatment in Low-Resource Settings.
    J Glob Oncol. 2016;3:658-665.
    PubMed     Text format     Abstract available

  35. JERONIMO J, Castle PE, Temin S, Denny L, et al
    Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline.
    J Glob Oncol. 2016;3:635-657.
    PubMed     Text format     Abstract available

  36. WU ES, Jeronimo J, Feldman S
    Barriers and Challenges to Treatment Alternatives for Early-Stage Cervical Cancer in Lower-Resource Settings.
    J Glob Oncol. 2017;3:572-582.
    PubMed     Text format     Abstract available

  37. ORANG'O E, Itsura P, Tonui P, Muliro H, et al
    Use of Palliative Cisplatinum for Advanced Cervical Cancer in a Resource-Poor Setting: A Case Series From Kenya.
    J Glob Oncol. 2016;3:539-544.
    PubMed     Text format     Abstract available

  38. CASTANON A, Landy R, Michalopoulos D, Bhudia R, et al
    Systematic Review and Meta-Analysis of Individual Patient Data to Assess the Sensitivity of Cervical Cytology for Diagnosis of Cervical Cancer in Low- and Middle-Income Countries.
    J Glob Oncol. 2017;3:524-538.
    PubMed     Text format     Abstract available


    J Womens Health (Larchmt)

  39. TOWNSEND JS, Steele CB, Hayes N, Bhatt A, et al
    Human Papillomavirus Vaccine as an Anticancer Vaccine: Collaborative Efforts to Promote Human Papillomavirus Vaccine in the National Comprehensive Cancer Control Program.
    J Womens Health (Larchmt). 2017;26:200-206.
    PubMed     Text format     Abstract available


    JAMA Oncol

  40. SUN M, Cole AP, Lipsitz SL, Trinh QD, et al
    Trends in Breast, Colorectal, and Cervical Cancer Incidence Following the Affordable Care Act: Implications for Cancer Screening.
    JAMA Oncol. 2017 Nov 2. doi: 10.1001/jamaoncol.2017.3861.
    PubMed     Text format    


    Mol Carcinog

  41. VARGHESE VK, Shukla V, Kabekkodu SP, Pandey D, et al
    DNA Methylation Regulated microRNAs in Human Cervical Cancer.
    Mol Carcinog. 2017 Oct 27. doi: 10.1002/mc.22761.
    PubMed     Text format     Abstract available


    Oncol Lett

  42. SUN X, Liu Y
    Activation of the Wnt/beta-catenin signaling pathway may contribute to cervical cancer pathogenesis via upregulation of Twist.
    Oncol Lett. 2017;14:4841-4844.
    PubMed     Text format     Abstract available

  43. STIASNY A, Freier CP, Kuhn C, Schulze S, et al
    The involvement of E6, p53, p16, MDM2 and Gal-3 in the clinical outcome of patients with cervical cancer.
    Oncol Lett. 2017;14:4467-4476.
    PubMed     Text format     Abstract available

  44. LV X, Hou M, Duan X
    Correlation analysis between the parameters of contrast-enhanced ultrasonography in evaluating cervical cancer metastasis and expression of E-cadherin.
    Oncol Lett. 2017;14:4641-4646.
    PubMed     Text format     Abstract available

  45. JIANG L, Shi S, Shi Q, Zhang H, et al
    Similarity in the functions of HIF-1alpha and HIF-2alpha proteins in cervical cancer cells.
    Oncol Lett. 2017;14:5643-5651.
    PubMed     Text format     Abstract available


    Oncotarget

  46. TSHOMO U, Franceschi S, Tshokey T, Tobgay T, et al
    Evaluation of cytology versus human papillomavirus-based cervical cancer screening algorithms in Bhutan.
    Oncotarget. 2017;8:72438-72446.
    PubMed     Text format     Abstract available

  47. ZHANG X, Wang Y, Cao Y, Zhang X, et al
    Increased CCL19 expression is associated with progression in cervical cancer.
    Oncotarget. 2017;8:73817-73825.
    PubMed     Text format     Abstract available

  48. YANG SF, Liu YF, Cheng CW, Yang WE, et al
    Impact of microRNA-34a and polymorphism of its target gene CA9 on susceptibility to uterine cervical cancer.
    Oncotarget. 2017;8:77860-77871.
    PubMed     Text format     Abstract available


    Pak J Pharm Sci

  49. FELHI S, Chaaibia M, Bakari S, Mansour RB, et al
    Anti-microbial screening and cytotoxic activity of aerial part of Thymelaea hirsuta L. essential oil growing in south-west Tunisia.
    Pak J Pharm Sci. 2017;30:87-91.
    PubMed     Text format     Abstract available


    Pathol Oncol Res

  50. DARRE T, Aboubakari AS, N'Bortche BK, Bassowa A, et al
    Association of Schistosomiasis with Cervical Cancer in Togo: the Consequence of this Association.
    Pathol Oncol Res. 2017 Oct 27. doi: 10.1007/s12253-017-0350.
    PubMed     Text format     Abstract available


    PeerJ

  51. REES HD, Lombardo AR, Tangoren CG, Meyers SJ, et al
    Knowledge and beliefs regarding cervical cancer screening and HPV vaccination among urban and rural women in Leon, Nicaragua.
    PeerJ. 2017;5:e3871.
    PubMed     Text format     Abstract available


    Pharmacoeconomics

  52. EKWUNIFE OI, O'Mahony JF, Gerber Grote A, Mosch C, et al
    Challenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations.
    Pharmacoeconomics. 2017;35:65-82.
    PubMed     Text format     Abstract available


    PLoS Med

  53. WANG J, Andrae B, Sundstrom K, Ploner A, et al
    Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
    PLoS Med. 2017;14:e1002414.
    PubMed     Text format     Abstract available


    PLoS One

  54. SCHMID BC, Carlson J, Rezniczek GA, Wyllie J, et al
    Examining word association networks: A cross-country comparison of women's perceptions of HPV testing and vaccination.
    PLoS One. 2017;12:e0185669.
    PubMed     Text format     Abstract available


    PLoS Pathog

  55. SOTO DR, Barton C, Munger K, McLaughlin-Drubin ME, et al
    KDM6A addiction of cervical carcinoma cell lines is triggered by E7 and mediated by p21CIP1 suppression of replication stress.
    PLoS Pathog. 2017;13:e1006661.
    PubMed     Text format     Abstract available

  56. RAJAGOPALAN D, Pandey AK, Xiuzhen MC, Lee KK, et al
    TIP60 represses telomerase expression by inhibiting Sp1 binding to the TERT promoter.
    PLoS Pathog. 2017;13:e1006681.
    PubMed     Text format     Abstract available


    Prev Med

  57. MAZA M, Gage JC
    Considerations for HPV primary screening in lower-middle income countries.
    Prev Med. 2017;98:39-41.
    PubMed     Text format     Abstract available

  58. KUHN L, Denny L
    The time is now to implement HPV testing for primary screening in low resource settings.
    Prev Med. 2017;98:42-44.
    PubMed     Text format     Abstract available

  59. AGENOR M, Muzny CA, Schick V, Austin EL, et al
    Sexual orientation and sexual health services utilization among women in the United States.
    Prev Med. 2017;95:74-81.
    PubMed     Text format     Abstract available


    Probiotics Antimicrob Proteins

  60. WANG KD, Xu DJ, Wang BY, Yan DH, et al
    Inhibitory Effect of Vaginal Lactobacillus Supernatants on Cervical Cancer Cells.
    Probiotics Antimicrob Proteins. 2017 Oct 25. doi: 10.1007/s12602-017-9339.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  61. SPURGEON ME, den Boon JA, Horswill M, Barthakur S, et al
    Human papillomavirus oncogenes reprogram the cervical cancer microenvironment independently of and synergistically with estrogen.
    Proc Natl Acad Sci U S A. 2017;114:E9076-E9085.
    PubMed     Text format     Abstract available


    Strahlenther Onkol

  62. DE BOER P, van de Schoot AJAJ, Westerveld H, Smit M, et al
    Target tailoring and proton beam therapy to reduce small bowel dose in cervical cancer radiotherapy : A comparison of benefits.
    Strahlenther Onkol. 2017 Nov 3. doi: 10.1007/s00066-017-1224.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: